Financials

News Ideas Discussions Technicals Seasonals

RGT fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ARGENT BIOPHARMA LIMITED ORD NPV (DI) operating, investing, and financing activities

RGT free cash flow for H2 24 is -3.63 M GBP. For 2024, RGT free cash flow was -7.8 M GBP and operating cash flow was -7.73 M GBP.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: GBP

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—